Letters and urgent communications 2021

Date published: 06 January 2021

Last updated: 15 January 2021

Topics:

Professional medical and environmental health advice

Advice from the Chief Medical Officer to HSC professionals for 2021

Documents

HSS (MD) 8/2021 - Supply Disruption Alert - Methylprednisolone Powder for Solution for Injection (All Strengths)
PDF (495 KB)

HSS (MD) 7/2021 - Support Doctors throughout the Covid-19 Pandemic
PDF (354 KB)

HSS (MD) 6/2021 - COVID-19 Therapeutic Alert – Interleukin-6 Inhibitors (Tocilizumab Or Sarilumab) for Patients admitted to Critical Care Settings with COVID-19 Pneumonia (Adults)
PDF (331 KB)

HSS (MD) 5/2021 - Data Capture from the Covid-19 Vaccination Programme
PDF (182 KB)

Interim Position Statement: Interleukin-6 inhibitors (tocilizumab or sarilumab) for patients admitted to ICU with COVID-19 pneumonia (adults)
PDF (197 KB)

HSS (MD) 4/2021 - Timing of Interval between Covid-19 Vaccine Doses
PDF (461 KB)

HSS (MD) 3/2021 - Seasonal Influenza Vaccination Programme 2020/21 – Extension to 50-64 Year Olds
PDF (293 KB)

HSS (MD) 2/2021 - Deployment of COVID-19 Vaccine Oxford / AstraZeneca - Governance, Handling and Preparation in General Practice
PDF (242 KB)

HSS (MD) 1/2021 - Lithium Carbonate (Priadel®) 200mg and 400mg Modified Release Tablets – Updated Supply Disruption Alert
PDF (791 KB)

Help viewing documents